NCT Number: NCT02720354
A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"
[11C]-dimethyl-diphenyl ammonium ([11C]-DMDPA) - A Phase I, Open-label, Safety and Tolerability, Radiation Dosimetry, Biodistribution, First-in-Human Study of a Novel 11C-labeled Tracer for Positron Emission Tomography Myocardial Perfusion Imaging
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–40 year
Sex eligibility
Male
Study type
Interventional
Phase
Phase 1
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- body mass index (BMI) between 18.0 and 30.0 kg/m2
- good health
- written informed consent
Exclusion criteria
- smokers
- subject receiving medication
- a blood transfusion in the 4 weeks prior to screening
- positive alcohol blood test
- Subjects who suffer from claustrophobia
- Subjects who have had a clinically significant illness
- Subjects exposed to radiation within 12 months prior to screening
Treatment and study plan
Primary outcomes
-
Measurement of absorbed radiation dose for all target organs in megabecquerel (the activity of a quantity of radioactive material in which one nucleus decays per second).
Time frame: within 80 minutes
Sponsors and collaborators
Lead sponsor
Synektik S.A.
Industry
Collaborators
- European Commission
Registry information
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Mar 25, 2016
- Registry last updated
- Oct 20, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Efficacy and Economics of Exercise Maintenance Post-Cardiac Rehabilitation
NCT01658683
Arterial Occlusive Diseases, Arteriosclerosis
Ottawa, Ontario, Canada
View Trial DetailsProspective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
NCT03253692
Arterial Occlusive Diseases, Arteriosclerosis
Lexington, Kentucky, United States
View Trial DetailsValidation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional Flow Reserve (FFR)
NCT07763769
Angina Pectoris, Angina, Stable
Washington D.C., District of Columbia, United States
View Trial DetailsA Study of Population and Sex-specific Troponin Cutoffs for Ruling Out Acute Myocardial Infarction
NCT05336435
Acute Coronary Syndrome, Angina Pectoris
Aabenraa, Denmark
View Trial Details